Sanara Medtech Inc (SMTI) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Sanara Medtech Inc (SMTI) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($3.95 Million) in capital expenditures ($82.16K). Check Sanara Medtech Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

$3.95 Million
USD

Capital Expenditures

$82.16K
USD

Data as of

Dec 2025
Most recent filing

Sanara Medtech Inc Capital Reinvestment Ratio (2016–2025)

This chart tracks Sanara Medtech Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Sanara Medtech Inc cash flow conversion.

Annual Capital Reinvestment Ratio for Sanara Medtech Inc (2016–2025)

Year-by-year Capital Reinvestment Ratio for Sanara Medtech Inc from 2016 to 2025. See SMTI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.68x $6.79 Million $4.63 Million ▲ +2127.0%
2018 0.03x $277.14K $8.48K ▲ +313.5%
2016 0.01x $409.25K $3.03K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow